1 / 20

Module 3: A ccenture

Module 3: A ccenture. Kevin Overholt January 27 th , 2014. Background Information. Accenture is an information technology firm specializing in consulting, technology and systems integration, and outsourcing services. Spinoff of Arthur Andersen’s consulting branch.

jeneil
Télécharger la présentation

Module 3: A ccenture

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Module 3: Accenture Kevin Overholt January 27th, 2014

  2. Background Information • Accenture is an information technology firm specializing in consulting, technology and systems integration, and outsourcing services. • Spinoff of Arthur Andersen’s consulting branch. • Current Stock Price: 81.18 • Shares Outstanding: 636.99MM • Market Cap: 51.71B • P/E Ratio: 17.29 • Net Income: 3.28B • Total Assets: 16.9B

  3. NEA Multiple • Pros: • None • Cons: • Negative NEA alters multiple • Doesn’t reflect true value (Shares trading at 81.18)

  4. NEA Multiple • Pros: • None • Cons: • Negative NEA alters multiple • Doesn’t reflect true value (Shares trading at 81.18)

  5. BV Multiple • Pros: • Shows market cap in relation to • industry premium • Cons: • High growth in tech field makes this valuation difficult • Large variation in industry multiples (Shares trading at 81.18)

  6. BV Multiple • Pros: • Shows market cap in relation to • industry premium • Cons: • High growth in tech field makes this valuation difficult • Large variation in industry multiples (Shares trading at 81.18)

  7. Enterprise Profit After Tax (EPAT) Multiple • Pros: • Similar EPAT multiples across industry • Cons: • Different sized companies • Different core business (Shares trading at 81.18)

  8. Enterprise Profit After Tax (EPAT) Multiple • Pros: • Similar EPAT multiples across industry • Cons: • Different sized companies • Different core business (Shares trading at 81.18)

  9. Enterprise Profit After Tax (EPAT) Multiple - Adjusted • Pros: • Adjustment for size/core business makes valuation more accurate • Cons: • Not enough market data (Shares trading at 81.18)

  10. NI Multiple • Pros: • Similar NI multiples across industry • Consistent EPS across industry • Cons: • Different core business (Shares trading at 81.18)

  11. NI Multiple • Pros: • Similar NI multiples across industry • Consistent EPS across industry • Cons: • Different core business (Shares trading at 81.18)

  12. Comprehensive Income Multiple • Pros: • Shows more insight towards income of the industry • Cons: • Doesn’t reflect core business • Differences in CI activities (Shares trading at 81.18)

  13. Comprehensive Income Multiple • Pros: • Shows more insight towards income of the industry • Cons: • Doesn’t reflect core business • Differences in CI activities (Shares trading at 81.18)

  14. Sales Multiple • Pros: • Sales is main focus of industry • Cons: • Multiples aren’t consistent • Different sources of revenue in industry (Shares trading at 81.18)

  15. Sales Multiple • Pros: • Sales is main focus of industry • Cons: • Multiples aren’t consistent • Different sources of revenue in industry (Shares trading at 81.18)

  16. (P-BV)/R&D Multiple • Pros: • R&D is crucial for all firms in this industry • Good signal of health and financial strength • Cons: • Large variation in amount spent on R&D (Shares trading at 81.18)

  17. (P-BV)/R&D Multiple • Pros: • R&D is crucial for all firms in this industry • Good signal of health and financial strength • Cons: • Large variation in amount spent on R&D (Shares trading at 81.18)

  18. Summary • NI Multiple and (P-BV)/R&D Multiple were the two multiples that, in theory, are most accurate. • Industry is vastly different, with each company focusing on different core strengths. • Multiples were consistently erratic and inconsistent with current price.

  19. Recommendation • Sell! • The current price consistently is larger than the market multiples indicate it should be. • Research and Development figures are not in line with the rest of the industry. • Negative NEA is troubling.

  20. Questions?

More Related